Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region

Description

List of Tables

The antibody discovery market size is expected to reach USD 20.41 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody discovery is the process of identifying and developing antibodies that can specifically bind to a target, such as a virus, bacterium, or cancer cell. It involves techniques such as hybridoma technology, phage display, or single B-cell screening to isolate and optimize effective antibodies. These antibodies are then characterized and tested for their potential use in diagnostics, therapeutics, or research.

Personalized medicine is transforming the way diseases are treated by focusing on therapies that are tailored to an individual's genetic makeup and condition. Antibodies play a key role in this approach as they can be engineered to target specific molecules in the body, such as those found in cancer cells. The demand for customized antibody therapies is rising as more people and doctors prefer treatments that are more precise and have fewer side effects. This shift is especially important in fields such as oncology, where no two patients respond exactly the same way to treatment. Antibody discovery technologies enable the identification and development of highly specific treatments tailored to different patient groups. This trend is encouraging pharmaceutical companies to invest more in research that supports personalized approaches. As awareness and success stories around personalized medicine grow, it pushes the antibody discovery market forward, making it an essential part of future healthcare.

Strategic collaborations between biotech companies, pharmaceutical giants, academic institutions, and research labs are playing a big role in advancing antibody discovery. These partnerships allow different organizations to share resources, knowledge, and technology, making the discovery process faster and more effective. A research lab may have an advanced technological setup, while a pharmaceutical company may have the funding and manufacturing capabilities. Collaborations further help in managing the high cost and risk associated with drug development. Many companies now enter co-development or licensing agreements to share profits and responsibilities. This trend has led to a growing number of antibody-related drugs entering clinical trials and eventually reaching patients.

Antibody Discovery Market Report Highlights

In 2024, the phage display segment dominated with the largest share due to its versatility, reliability, and ability to produce high-affinity antibodies in a relatively short time.

The pharmaceutical and biotechnology industry segment is expected to experience significant growth during the forecast period as these companies are increasingly focused on developing biologic drugs, including monoclonal antibodies, to treat a wide range of conditions such as cancer, autoimmune diseases, and infectious diseases.

In 2024, North America dominated the antibody discovery market with the largest share due to its strong biomedical research infrastructure and consistent investments in life sciences.

The Asia Pacific antibody discovery market is experiencing significant growth driven by expanding biotech industries, supportive government initiatives, and increasing investments in healthcare research.

A few global key market players are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, and Twist Bioscience.

Polaris Market Research has segmented the antibody discovery market report on the basis of method, antibody type, end user, and region:

By Method (Revenue - USD Billion, 2020-2034)

Phage Display

Hybridoma

Others

By Antibody Type (Revenue - USD Billion, 2020-2034)

Humanized Antibody

Human Antibody

Chimeric Antibody

Murine Antibody

By End User (Revenue - USD Billion, 2020-2034)

Pharmaceutical and Biotechnology industry

Research laboratory

Academic laboratory

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM5947

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Antibody Discovery Market Insights

4.1. Antibody Discovery Market - Market Snapshot
4.2. Antibody Discovery Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Prevalence of Chronic and Infectious Disease
  - 4.2.1.2. Increase in Investment in Biopharmaceutical R&D
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Initial Cost of Manufacturing
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Antibody Discovery Market Trends
4.6. Value Chain Analysis

5. Global Antibody Discovery Market, by Method

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
5.3. Phage Display
- 5.3.1. Global Antibody Discovery Market, by Phage Display, by Region, 2020-2034 (USD billion)
5.4. Hybridoma
- 5.4.1. Global Antibody Discovery Market, by Hybridoma, by Region, 2020-2034 (USD billion)
5.5. Others
- 5.5.1. Global Antibody Discovery Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Antibody Discovery Market, by Antibody Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
6.3. Humanized Antibody
- 6.3.1. Global Antibody Discovery Market, by Humanized Antibody, by Region, 2020-2034 (USD billion)
6.4. Human Antibody
- 6.4.1. Global Antibody Discovery Market, by Human Antibody, by Region, 2020-2034 (USD billion)
6.5. Chimeric Antibody
- 6.5.1. Global Antibody Discovery Market, by Chimeric Antibody, by Region, 2020-2034 (USD billion)
6.6. Murine Antibody
- 6.6.1. Global Antibody Discovery Market, by Murine Antibody, by Region, 2020-2034 (USD billion)

7. Global Antibody Discovery Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
7.3. Pharmaceutical and Biotechnology industry
- 7.3.1. Global Antibody Discovery Market, by Pharmaceutical and Biotechnology industry, by Region, 2020-2034 (USD billion)
7.4. Research laboratory
- 7.4.1. Global Antibody Discovery Market, by Research laboratory, by Region, 2020-2034 (USD billion)
7.5. Academic laboratory
- 7.5.1. Global Antibody Discovery Market, by Academic laboratory, by Region, 2020-2034 (USD billion)

8. Global Antibody Discovery Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
8.3. Antibody Discovery Market - North America
- 8.3.1. North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.3.2. North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.3.3. North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.3.4. Antibody Discovery Market - U.S.
  - 8.3.4.1. U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.3.4.2. U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.3.4.3. U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.3.5. Antibody Discovery Market - Canada
  - 8.3.5.1. Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.3.5.2. Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.3.5.3. Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
8.4. Antibody Discovery Market - Europe
- 8.4.1. Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.2. Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.3. Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.4. Antibody Discovery Market - UK
  - 8.4.4.1. UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.4.2. UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.4.3. UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.5. Antibody Discovery Market - France
  - 8.4.5.1. France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.5.2. France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.5.3. France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.6. Antibody Discovery Market - Germany
  - 8.4.6.1. Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.6.2. Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.6.3. Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.7. Antibody Discovery Market - Italy
  - 8.4.7.1. Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.7.2. Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.7.3. Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.8. Antibody Discovery Market - Spain
  - 8.4.8.1. Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.8.2. Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.8.3. Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.9. Antibody Discovery Market - Netherlands
  - 8.4.9.1. Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.9.2. Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.9.3. Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.10. Antibody Discovery Market - Russia
  - 8.4.10.1. Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.10.2. Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.10.3. Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.11. Antibody Discovery Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.4.11.2. Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.4.11.3. Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
8.5. Antibody Discovery Market - Asia Pacific
- 8.5.1. Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.2. Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.3. Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.4. Antibody Discovery Market - China
  - 8.5.4.1. China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.4.2. China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.4.3. China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.5. Antibody Discovery Market - India
  - 8.5.5.1. India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.5.2. India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.5.3. India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.6. Antibody Discovery Market - Malaysia
  - 8.5.6.1. Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.6.2. Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.6.3. Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.7. Antibody Discovery Market - Japan
  - 8.5.7.1. Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.7.2. Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.7.3. Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.8. Antibody Discovery Market - Indonesia
  - 8.5.8.1. Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.8.2. Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.8.3. Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.9. Antibody Discovery Market - South Korea
  - 8.5.9.1. South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.9.2. South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.9.3. South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.10. Antibody Discovery Market - Australia
  - 8.5.10.1. Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.10.2. Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.10.3. Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.11. Antibody Discovery Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.5.11.2. Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.5.11.3. Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
8.6. Antibody Discovery Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.2. Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.3. Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.4. Antibody Discovery Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.6.4.2. Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.6.4.3. Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.5. Antibody Discovery Market - UAE
  - 8.6.5.1. UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.6.5.2. UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.6.5.3. UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.6. Antibody Discovery Market - Israel
  - 8.6.6.1. Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.6.6.2. Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.6.6.3. Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.7. Antibody Discovery Market - South Africa
  - 8.6.7.1. South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.6.7.2. South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.6.7.3. South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.8. Antibody Discovery Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.6.8.2. Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.6.8.3. Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
8.7. Antibody Discovery Market - Latin America
- 8.7.1. Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.2. Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.3. Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.4. Antibody Discovery Market - Mexico
  - 8.7.4.1. Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.7.4.2. Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.7.4.3. Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.5. Antibody Discovery Market - Brazil
  - 8.7.5.1. Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.7.5.2. Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.7.5.3. Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.6. Antibody Discovery Market - Argentina
  - 8.7.6.1. Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.7.6.2. Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.7.6.3. Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.7. Antibody Discovery Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  - 8.7.7.2. Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  - 8.7.7.3. Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Biocytogen
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Method Benchmarking
- 10.1.4. Recent Development
10.2. Charles River Laboratories
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Method Benchmarking
- 10.2.4. Recent Development
10.3. Creative Biolabs
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Method Benchmarking
- 10.3.4. Recent Development
10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Method Benchmarking
- 10.4.4. Recent Development
10.5. Eurofins Scientific
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Method Benchmarking
- 10.5.4. Recent Development
10.6. Evotec
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Method Benchmarking
- 10.6.4. Recent Development
10.7. Fairjourney Biologics S.A
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Method Benchmarking
- 10.7.4. Recent Development
10.8. Genscript Technology Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Method Benchmarking
- 10.8.4. Recent Development
10.9. Sartorius AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Method Benchmarking
- 10.9.4. Recent Development
10.10. Twist Bioscience
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Method Benchmarking
- 10.10.4. Recent Development